ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 78 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,037,000 | -27.5% | 4,250 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $5,568,000 | -25.6% | 4,250 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $7,480,000 | -18.9% | 4,250 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $9,222,000 | -38.0% | 4,250 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $14,875,000 | -64.5% | 4,250 | 0.0% | 0.00% | -75.0% |
| Q1 2021 | $41,905,000 | -40.1% | 4,250 | -34.1% | 0.01% | -46.7% |
| Q4 2020 | $69,918,000 | +1574.3% | 6,450 | +3125.0% | 0.02% | +1400.0% |
| Q2 2020 | $4,176,000 | -85.4% | 200 | -93.2% | 0.00% | -87.5% |
| Q1 2020 | $28,538,000 | – | 2,921 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |